Roswell Biotechnologies Inc

Roswell was founded in 2014 by veterans of genomic sequencing who understood that precision medicine would fail to live up to its promise without a new technology. If digitizing cell phones could radically transform the way we live, what could we do if we digitized biology? With this vision, Paul Mola and Barry Merriman set out to develop the first molecular electronics chip to digitize biology and transform health. Devices informed by a dynamic knowledge base will modernize diagnostics and disease surveillance by moving testing from labs into the hands of individuals.